To: Dwight E. Karlsen who wrote (8906 ) 11/10/1997 1:41:00 PM From: Scrapps Read Replies (1) | Respond to of 22053
The following are selected from the top MarketScope MarketMovers as of 10:05 a.m.:3COM CORP (Nasdaq:COMS - news) Up 1 to 39 1/8... Wheat First adds to analyst action list, reiterates buy. CRESTAR FINANCIAL CORP (NYSE:CF - news) Up 1 to 49 1/8... Wheat First upgrades to buy from outperform. LASER INDUSTRIES LTD (Nasdaq:LASRF - news) Up 4 1/8 to 27 3/8... Agrees to be acquired by ESC MEDICAL SYSTEMS LTD in deal valued at about $270M... Terms: 0.75 ESCMF share per LASRF share. IMMUNEX CORP (Nasdaq:IMNX - news) Up 3 5/8 to 71 3/8... In Phase III study, patients with advanced rheumatoid arthritis treated with 25mg dose of co.'s Enbrel experienced 71% reduction in painful joint counts vs. placebo group. MEDICAL RESOURCES INC (Nasdaq:MRII - news) Down 2 to 10... Sees $0.16-$0.19 vs. $0.15 3Q EPS (fully diluted) on revenues of about $60M... President, COO William Farrell resigns... Tucker downgrades to hold. DANKA BUSINESS SYSTEMS PLC (Nasdaq:DANKY - news) Up 2 3/8 to 38 3/8.. In new deal with HEWLETT-PACKARD CO where DANKY to distribute, service HP LaserJet printers, scanners, peripherals, consumables... Prudential reiterates buy, single best idea. ESC MEDICAL SYSTEMS LTD (Nasdaq:ESCMF - news) Down 1 3/4 to 40 1/4... Agrees to acquire LASER INDUSTRIES LTD in deal valued at $270M... Terms: 0.75 ESCMF share per LASRF share. CKS GROUP INC (Nasdaq:CKSG - news) Down 21 3/8 to 14 7/8... Sees $0.06-$0.10 4Q EPS on revenues of $32M-$34M, significantly below expectations of analysts... Goldman removes from recommended list, now rates market performer... BT Alex Brown downgrades. CENTOCOR INC (Nasdaq:CNTO - news) Down 6 to 46 1/8... Co.'s Avakine for RA showed reduction of more than 75% in response variables in patients receiving 3 or 10 mg/kg... Merrill downgrades as some patients in study developed lymphoma. STEEL DYNAMICS INC (Nasdaq:STLD - news) Up 1 to 21 5/8... Goldman initiates coverage with market outperformer. --------------------------------------------------------------------------------